Table of Content

1 Semi-Solid Dosage Form Market Overview
1.1 Semi-Solid Dosage Form Product Overview
1.2 Semi-Solid Dosage Form Market Segment by Type
1.2.1 Ointments
1.2.2 Gels
1.2.3 Others
1.3 Global Semi-Solid Dosage Form Market Size by Type
1.3.1 Global Semi-Solid Dosage Form Market Size Overview by Type (2018-2029)
1.3.2 Global Semi-Solid Dosage Form Historic Market Size Review by Type (2018-2024)
1.3.3 Global Semi-Solid Dosage Form Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Semi-Solid Dosage Form Sales Breakdown by Type (2018-2024)
1.4.2 Europe Semi-Solid Dosage Form Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Semi-Solid Dosage Form Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Semi-Solid Dosage Form Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Semi-Solid Dosage Form Sales Breakdown by Type (2018-2024)
2 Global Semi-Solid Dosage Form Market Competition by Company
2.1 Global Top Players by Semi-Solid Dosage Form Sales (2018-2024)
2.2 Global Top Players by Semi-Solid Dosage Form Revenue (2018-2024)
2.3 Global Top Players by Semi-Solid Dosage Form Price (2018-2024)
2.4 Global Top Manufacturers Semi-Solid Dosage Form Manufacturing Base Distribution, Sales Area, Product Type
2.5 Semi-Solid Dosage Form Market Competitive Situation and Trends
2.5.1 Semi-Solid Dosage Form Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Semi-Solid Dosage Form Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Semi-Solid Dosage Form as of 2022)
2.7 Date of Key Manufacturers Enter into Semi-Solid Dosage Form Market
2.8 Key Manufacturers Semi-Solid Dosage Form Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Semi-Solid Dosage Form Status and Outlook by Region
3.1 Global Semi-Solid Dosage Form Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Semi-Solid Dosage Form Historic Market Size by Region
3.2.1 Global Semi-Solid Dosage Form Sales in Volume by Region (2018-2024)
3.2.2 Global Semi-Solid Dosage Form Sales in Value by Region (2018-2024)
3.2.3 Global Semi-Solid Dosage Form Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Semi-Solid Dosage Form Forecasted Market Size by Region
3.3.1 Global Semi-Solid Dosage Form Sales in Volume by Region (2024-2029)
3.3.2 Global Semi-Solid Dosage Form Sales in Value by Region (2024-2029)
3.3.3 Global Semi-Solid Dosage Form Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Semi-Solid Dosage Form by Application
4.1 Semi-Solid Dosage Form Market Segment by Application
4.1.1 Skin
4.1.2 Nasal Cavity
4.1.3 Vaginal Cavity
4.1.4 Rectal Cavity
4.1.5 Others
4.2 Global Semi-Solid Dosage Form Market Size by Application
4.2.1 Global Semi-Solid Dosage Form Market Size Overview by Application (2018-2029)
4.2.2 Global Semi-Solid Dosage Form Historic Market Size Review by Application (2018-2024)
4.2.3 Global Semi-Solid Dosage Form Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Semi-Solid Dosage Form Sales Breakdown by Application (2018-2024)
4.3.2 Europe Semi-Solid Dosage Form Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Semi-Solid Dosage Form Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Semi-Solid Dosage Form Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Semi-Solid Dosage Form Sales Breakdown by Application (2018-2024)
5 North America Semi-Solid Dosage Form by Country
5.1 North America Semi-Solid Dosage Form Historic Market Size by Country
5.1.1 North America Semi-Solid Dosage Form Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Semi-Solid Dosage Form Sales in Volume by Country (2018-2024)
5.1.3 North America Semi-Solid Dosage Form Sales in Value by Country (2018-2024)
5.2 North America Semi-Solid Dosage Form Forecasted Market Size by Country
5.2.1 North America Semi-Solid Dosage Form Sales in Volume by Country (2024-2029)
5.2.2 North America Semi-Solid Dosage Form Sales in Value by Country (2024-2029)
6 Europe Semi-Solid Dosage Form by Country
6.1 Europe Semi-Solid Dosage Form Historic Market Size by Country
6.1.1 Europe Semi-Solid Dosage Form Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Semi-Solid Dosage Form Sales in Volume by Country (2018-2024)
6.1.3 Europe Semi-Solid Dosage Form Sales in Value by Country (2018-2024)
6.2 Europe Semi-Solid Dosage Form Forecasted Market Size by Country
6.2.1 Europe Semi-Solid Dosage Form Sales in Volume by Country (2024-2029)
6.2.2 Europe Semi-Solid Dosage Form Sales in Value by Country (2024-2029)
7 Asia-Pacific Semi-Solid Dosage Form by Region
7.1 Asia-Pacific Semi-Solid Dosage Form Historic Market Size by Region
7.1.1 Asia-Pacific Semi-Solid Dosage Form Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Semi-Solid Dosage Form Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Semi-Solid Dosage Form Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Semi-Solid Dosage Form Forecasted Market Size by Region
7.2.1 Asia-Pacific Semi-Solid Dosage Form Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Semi-Solid Dosage Form Sales in Value by Region (2024-2029)
8 Latin America Semi-Solid Dosage Form by Country
8.1 Latin America Semi-Solid Dosage Form Historic Market Size by Country
8.1.1 Latin America Semi-Solid Dosage Form Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Semi-Solid Dosage Form Sales in Volume by Country (2018-2024)
8.1.3 Latin America Semi-Solid Dosage Form Sales in Value by Country (2018-2024)
8.2 Latin America Semi-Solid Dosage Form Forecasted Market Size by Country
8.2.1 Latin America Semi-Solid Dosage Form Sales in Volume by Country (2024-2029)
8.2.2 Latin America Semi-Solid Dosage Form Sales in Value by Country (2024-2029)
9 Middle East and Africa Semi-Solid Dosage Form by Country
9.1 Middle East and Africa Semi-Solid Dosage Form Historic Market Size by Country
9.1.1 Middle East and Africa Semi-Solid Dosage Form Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Semi-Solid Dosage Form Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Semi-Solid Dosage Form Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Semi-Solid Dosage Form Forecasted Market Size by Country
9.2.1 Middle East and Africa Semi-Solid Dosage Form Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Semi-Solid Dosage Form Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Johnson & Johnson
10.1.1 Johnson & Johnson Company Information
10.1.2 Johnson & Johnson Introduction and Business Overview
10.1.3 Johnson & Johnson Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Johnson & Johnson Semi-Solid Dosage Form Products Offered
10.1.5 Johnson & Johnson Recent Development
10.2 Merck & Co
10.2.1 Merck & Co Company Information
10.2.2 Merck & Co Introduction and Business Overview
10.2.3 Merck & Co Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Merck & Co Semi-Solid Dosage Form Products Offered
10.2.5 Merck & Co Recent Development
10.3 Bayer AG
10.3.1 Bayer AG Company Information
10.3.2 Bayer AG Introduction and Business Overview
10.3.3 Bayer AG Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Bayer AG Semi-Solid Dosage Form Products Offered
10.3.5 Bayer AG Recent Development
10.4 Hisamitsu Pharmaceutical
10.4.1 Hisamitsu Pharmaceutical Company Information
10.4.2 Hisamitsu Pharmaceutical Introduction and Business Overview
10.4.3 Hisamitsu Pharmaceutical Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Hisamitsu Pharmaceutical Semi-Solid Dosage Form Products Offered
10.4.5 Hisamitsu Pharmaceutical Recent Development
10.5 Glenmark Pharmaceuticals
10.5.1 Glenmark Pharmaceuticals Company Information
10.5.2 Glenmark Pharmaceuticals Introduction and Business Overview
10.5.3 Glenmark Pharmaceuticals Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Glenmark Pharmaceuticals Semi-Solid Dosage Form Products Offered
10.5.5 Glenmark Pharmaceuticals Recent Development
10.6 Cipla Ltd
10.6.1 Cipla Ltd Company Information
10.6.2 Cipla Ltd Introduction and Business Overview
10.6.3 Cipla Ltd Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Cipla Ltd Semi-Solid Dosage Form Products Offered
10.6.5 Cipla Ltd Recent Development
10.7 Nestlé SA
10.7.1 Nestlé SA Company Information
10.7.2 Nestlé SA Introduction and Business Overview
10.7.3 Nestlé SA Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Nestlé SA Semi-Solid Dosage Form Products Offered
10.7.5 Nestlé SA Recent Development
10.8 Novartis AG
10.8.1 Novartis AG Company Information
10.8.2 Novartis AG Introduction and Business Overview
10.8.3 Novartis AG Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Novartis AG Semi-Solid Dosage Form Products Offered
10.8.5 Novartis AG Recent Development
10.9 GlaxoSmithKline plc
10.9.1 GlaxoSmithKline plc Company Information
10.9.2 GlaxoSmithKline plc Introduction and Business Overview
10.9.3 GlaxoSmithKline plc Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2018-2024)
10.9.4 GlaxoSmithKline plc Semi-Solid Dosage Form Products Offered
10.9.5 GlaxoSmithKline plc Recent Development
10.10 Bausch Health Companies
10.10.1 Bausch Health Companies Company Information
10.10.2 Bausch Health Companies Introduction and Business Overview
10.10.3 Bausch Health Companies Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Bausch Health Companies Semi-Solid Dosage Form Products Offered
10.10.5 Bausch Health Companies Recent Development
10.11 Allergan plc
10.11.1 Allergan plc Company Information
10.11.2 Allergan plc Introduction and Business Overview
10.11.3 Allergan plc Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Allergan plc Semi-Solid Dosage Form Products Offered
10.11.5 Allergan plc Recent Development
10.12 Biofrontera, Inc.
10.12.1 Biofrontera, Inc. Company Information
10.12.2 Biofrontera, Inc. Introduction and Business Overview
10.12.3 Biofrontera, Inc. Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Biofrontera, Inc. Semi-Solid Dosage Form Products Offered
10.12.5 Biofrontera, Inc. Recent Development
10.13 Crown Laboratories Inc.
10.13.1 Crown Laboratories Inc. Company Information
10.13.2 Crown Laboratories Inc. Introduction and Business Overview
10.13.3 Crown Laboratories Inc. Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Crown Laboratories Inc. Semi-Solid Dosage Form Products Offered
10.13.5 Crown Laboratories Inc. Recent Development
10.14 Akorn Inc. (US)
10.14.1 Akorn Inc. (US) Company Information
10.14.2 Akorn Inc. (US) Introduction and Business Overview
10.14.3 Akorn Inc. (US) Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Akorn Inc. (US) Semi-Solid Dosage Form Products Offered
10.14.5 Akorn Inc. (US) Recent Development
10.15 Ingenus Pharmaceuticals
10.15.1 Ingenus Pharmaceuticals Company Information
10.15.2 Ingenus Pharmaceuticals Introduction and Business Overview
10.15.3 Ingenus Pharmaceuticals Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Ingenus Pharmaceuticals Semi-Solid Dosage Form Products Offered
10.15.5 Ingenus Pharmaceuticals Recent Development
10.16 Sun Pharmaceuticals
10.16.1 Sun Pharmaceuticals Company Information
10.16.2 Sun Pharmaceuticals Introduction and Business Overview
10.16.3 Sun Pharmaceuticals Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Sun Pharmaceuticals Semi-Solid Dosage Form Products Offered
10.16.5 Sun Pharmaceuticals Recent Development
10.17 Crescita Therapeutics Inc.
10.17.1 Crescita Therapeutics Inc. Company Information
10.17.2 Crescita Therapeutics Inc. Introduction and Business Overview
10.17.3 Crescita Therapeutics Inc. Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Crescita Therapeutics Inc. Semi-Solid Dosage Form Products Offered
10.17.5 Crescita Therapeutics Inc. Recent Development
10.18 Mylan N.V.
10.18.1 Mylan N.V. Company Information
10.18.2 Mylan N.V. Introduction and Business Overview
10.18.3 Mylan N.V. Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Mylan N.V. Semi-Solid Dosage Form Products Offered
10.18.5 Mylan N.V. Recent Development
10.19 Encore Dermatology, Inc.
10.19.1 Encore Dermatology, Inc. Company Information
10.19.2 Encore Dermatology, Inc. Introduction and Business Overview
10.19.3 Encore Dermatology, Inc. Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Encore Dermatology, Inc. Semi-Solid Dosage Form Products Offered
10.19.5 Encore Dermatology, Inc. Recent Development
10.20 LEO Pharma
10.20.1 LEO Pharma Company Information
10.20.2 LEO Pharma Introduction and Business Overview
10.20.3 LEO Pharma Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2018-2024)
10.20.4 LEO Pharma Semi-Solid Dosage Form Products Offered
10.20.5 LEO Pharma Recent Development
10.21 Almirall, S.A
10.21.1 Almirall, S.A Company Information
10.21.2 Almirall, S.A Introduction and Business Overview
10.21.3 Almirall, S.A Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2018-2024)
10.21.4 Almirall, S.A Semi-Solid Dosage Form Products Offered
10.21.5 Almirall, S.A Recent Development
10.22 Aclaris Therapeutics, Inc.
10.22.1 Aclaris Therapeutics, Inc. Company Information
10.22.2 Aclaris Therapeutics, Inc. Introduction and Business Overview
10.22.3 Aclaris Therapeutics, Inc. Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2018-2024)
10.22.4 Aclaris Therapeutics, Inc. Semi-Solid Dosage Form Products Offered
10.22.5 Aclaris Therapeutics, Inc. Recent Development
10.23 Taro Pharmaceutical Industries Ltd.
10.23.1 Taro Pharmaceutical Industries Ltd. Company Information
10.23.2 Taro Pharmaceutical Industries Ltd. Introduction and Business Overview
10.23.3 Taro Pharmaceutical Industries Ltd. Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2018-2024)
10.23.4 Taro Pharmaceutical Industries Ltd. Semi-Solid Dosage Form Products Offered
10.23.5 Taro Pharmaceutical Industries Ltd. Recent Development
10.24 Teligent Pharma
10.24.1 Teligent Pharma Company Information
10.24.2 Teligent Pharma Introduction and Business Overview
10.24.3 Teligent Pharma Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2018-2024)
10.24.4 Teligent Pharma Semi-Solid Dosage Form Products Offered
10.24.5 Teligent Pharma Recent Development
10.25 Perrigo Pharma
10.25.1 Perrigo Pharma Company Information
10.25.2 Perrigo Pharma Introduction and Business Overview
10.25.3 Perrigo Pharma Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2018-2024)
10.25.4 Perrigo Pharma Semi-Solid Dosage Form Products Offered
10.25.5 Perrigo Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Semi-Solid Dosage Form Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Semi-Solid Dosage Form Industrial Chain Analysis
11.4 Semi-Solid Dosage Form Market Dynamics
11.4.1 Semi-Solid Dosage Form Industry Trends
11.4.2 Semi-Solid Dosage Form Market Drivers
11.4.3 Semi-Solid Dosage Form Market Challenges
11.4.4 Semi-Solid Dosage Form Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Semi-Solid Dosage Form Distributors
12.3 Semi-Solid Dosage Form Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Ointments
Table 2. Major Company of Gels
Table 3. Major Company of Others
Table 4. Global Semi-Solid Dosage Form Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Semi-Solid Dosage Form Sales by Type (2018-2024) & (K Units)
Table 6. Global Semi-Solid Dosage Form Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Semi-Solid Dosage Form Sales by Type (2018-2024) & (US& Million)
Table 8. Global Semi-Solid Dosage Form Market Share in Value by Type (2018-2024)
Table 9. Global Semi-Solid Dosage Form Price by Type (2018-2024) & (USD/Unit)
Table 10. Global Semi-Solid Dosage Form Sales by Type (2024-2029) & (K Units)
Table 11. Global Semi-Solid Dosage Form Sales Market Share in Volume by Type (2024-2029)
Table 12. Global Semi-Solid Dosage Form Sales by Type (2024-2029) & (US$ Million)
Table 13. Global Semi-Solid Dosage Form Sales Market Share in Value by Type (2024-2029)
Table 14. Global Semi-Solid Dosage Form Price by Type (2024-2029) & (USD/Unit)
Table 15. North America Semi-Solid Dosage Form Sales by Type (2018-2024) & (K Units)
Table 16. North America Semi-Solid Dosage Form Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Semi-Solid Dosage Form Sales (K Units) by Type (2018-2024)
Table 18. Europe Semi-Solid Dosage Form Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Semi-Solid Dosage Form Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Semi-Solid Dosage Form Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Semi-Solid Dosage Form Sales (K Units) by Type (2018-2024)
Table 22. Latin America Semi-Solid Dosage Form Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Semi-Solid Dosage Form Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Semi-Solid Dosage Form Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Semi-Solid Dosage Form Sales by Company (2018-2024) & (K Units)
Table 26. Global Semi-Solid Dosage Form Sales Share by Company (2018-2024)
Table 27. Global Semi-Solid Dosage Form Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Semi-Solid Dosage Form Revenue Share by Company (2018-2024)
Table 29. Global Market Semi-Solid Dosage Form Price by Company (2018-2024) & (USD/Unit)
Table 30. Global Semi-Solid Dosage Form Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Semi-Solid Dosage Form Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Semi-Solid Dosage Form as of 2022)
Table 33. Date of Key Manufacturers Enter into Semi-Solid Dosage Form Market
Table 34. Key Manufacturers Semi-Solid Dosage Form Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Semi-Solid Dosage Form Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 37. Global Semi-Solid Dosage Form Sales by Region (2018-2024) & (K Units)
Table 38. Global Semi-Solid Dosage Form Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Semi-Solid Dosage Form Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Semi-Solid Dosage Form Sales Market Share in Value by Region (2018-2024)
Table 41. Global Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 42. Global Semi-Solid Dosage Form Sales by Region (2024-2029) & (K Units)
Table 43. Global Semi-Solid Dosage Form Sales Market Share in Volume by Region (2024-2029)
Table 44. Global Semi-Solid Dosage Form Sales by Region (2024-2029) & (US$ Million)
Table 45. Global Semi-Solid Dosage Form Sales Market Share in Value by Region (2024-2029)
Table 46. Global Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
Table 47. Global Semi-Solid Dosage Form Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 48. Global Semi-Solid Dosage Form Sales by Application (2018-2024) & (K Units)
Table 49. Global Semi-Solid Dosage Form Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Semi-Solid Dosage Form Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Semi-Solid Dosage Form Sales Market Share in Value by Application (2018-2024)
Table 52. Global Semi-Solid Dosage Form Price by Application (2018-2024) & (USD/Unit)
Table 53. Global Semi-Solid Dosage Form Sales by Application (2024-2029) & (K Units)
Table 54. Global Semi-Solid Dosage Form Sales Market Share in Volume by Application (2024-2029)
Table 55. Global Semi-Solid Dosage Form Sales by Application (2024-2029) & (US$ Million)
Table 56. Global Semi-Solid Dosage Form Sales Market Share in Value by Application (2024-2029)
Table 57. Global Semi-Solid Dosage Form Price by Application (2024-2029) & (USD/Unit)
Table 58. North America Semi-Solid Dosage Form Sales by Application (2018-2024) (K Units)
Table 59. North America Semi-Solid Dosage Form Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Semi-Solid Dosage Form Sales by Application (2018-2024) (K Units)
Table 61. Europe Semi-Solid Dosage Form Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Semi-Solid Dosage Form Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Semi-Solid Dosage Form Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Semi-Solid Dosage Form Sales by Application (2018-2024) (K Units)
Table 65. Latin America Semi-Solid Dosage Form Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Semi-Solid Dosage Form Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Semi-Solid Dosage Form Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Semi-Solid Dosage Form Sales by Country (2018-2024) & (K Units)
Table 69. North America Semi-Solid Dosage Form Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Semi-Solid Dosage Form Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Semi-Solid Dosage Form Sales Market Share in Value by Country (2018-2024)
Table 72. North America Semi-Solid Dosage Form Sales by Country (2024-2029) & (K Units)
Table 73. North America Semi-Solid Dosage Form Sales Market Share in Volume by Country (2024-2029)
Table 74. North America Semi-Solid Dosage Form Sales by Country (2024-2029) & (US$ Million)
Table 75. North America Semi-Solid Dosage Form Sales Market Share in Value by Country (2024-2029)
Table 76. Europe Semi-Solid Dosage Form Sales by Country (2018-2024) & (K Units)
Table 77. Europe Semi-Solid Dosage Form Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Semi-Solid Dosage Form Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Semi-Solid Dosage Form Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Semi-Solid Dosage Form Sales by Country (2024-2029) & (K Units)
Table 81. Europe Semi-Solid Dosage Form Sales Market Share in Volume by Country (2024-2029)
Table 82. Europe Semi-Solid Dosage Form Sales by Country (2024-2029) & (US$ Million)
Table 83. Europe Semi-Solid Dosage Form Sales Market Share in Value by Country (2024-2029)
Table 84. Asia-Pacific Semi-Solid Dosage Form Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Semi-Solid Dosage Form Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Semi-Solid Dosage Form Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Semi-Solid Dosage Form Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Semi-Solid Dosage Form Sales by Region (2024-2029) & (K Units)
Table 89. Asia-Pacific Semi-Solid Dosage Form Sales Market Share in Volume by Region (2024-2029)
Table 90. Asia-Pacific Semi-Solid Dosage Form Sales by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific Semi-Solid Dosage Form Sales Market Share in Value by Region (2024-2029)
Table 92. Latin America Semi-Solid Dosage Form Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Semi-Solid Dosage Form Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Semi-Solid Dosage Form Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Semi-Solid Dosage Form Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Semi-Solid Dosage Form Sales by Country (2024-2029) & (K Units)
Table 97. Latin America Semi-Solid Dosage Form Sales Market Share in Volume by Country (2024-2029)
Table 98. Latin America Semi-Solid Dosage Form Sales by Country (2024-2029) & (US$ Million)
Table 99. Latin America Semi-Solid Dosage Form Sales Market Share in Value by Country (2024-2029)
Table 100. Middle East and Africa Semi-Solid Dosage Form Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Semi-Solid Dosage Form Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Semi-Solid Dosage Form Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Semi-Solid Dosage Form Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Semi-Solid Dosage Form Sales by Country (2024-2029) & (K Units)
Table 105. Middle East and Africa Semi-Solid Dosage Form Sales Market Share in Volume by Country (2024-2029)
Table 106. Middle East and Africa Semi-Solid Dosage Form Sales by Country (2024-2029) & (US$ Million)
Table 107. Middle East and Africa Semi-Solid Dosage Form Sales Market Share in Value by Country (2024-2029)
Table 108. Johnson & Johnson Company Information
Table 109. Johnson & Johnson Introduction and Business Overview
Table 110. Johnson & Johnson Semi-Solid Dosage Form Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. Johnson & Johnson Semi-Solid Dosage Form Product
Table 112. Johnson & Johnson Recent Development
Table 113. Merck & Co Company Information
Table 114. Merck & Co Introduction and Business Overview
Table 115. Merck & Co Semi-Solid Dosage Form Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. Merck & Co Semi-Solid Dosage Form Product
Table 117. Merck & Co Recent Development
Table 118. Bayer AG Company Information
Table 119. Bayer AG Introduction and Business Overview
Table 120. Bayer AG Semi-Solid Dosage Form Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. Bayer AG Semi-Solid Dosage Form Product
Table 122. Bayer AG Recent Development
Table 123. Hisamitsu Pharmaceutical Company Information
Table 124. Hisamitsu Pharmaceutical Introduction and Business Overview
Table 125. Hisamitsu Pharmaceutical Semi-Solid Dosage Form Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Hisamitsu Pharmaceutical Semi-Solid Dosage Form Product
Table 127. Hisamitsu Pharmaceutical Recent Development
Table 128. Glenmark Pharmaceuticals Company Information
Table 129. Glenmark Pharmaceuticals Introduction and Business Overview
Table 130. Glenmark Pharmaceuticals Semi-Solid Dosage Form Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Glenmark Pharmaceuticals Semi-Solid Dosage Form Product
Table 132. Glenmark Pharmaceuticals Recent Development
Table 133. Cipla Ltd Company Information
Table 134. Cipla Ltd Introduction and Business Overview
Table 135. Cipla Ltd Semi-Solid Dosage Form Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Cipla Ltd Semi-Solid Dosage Form Product
Table 137. Cipla Ltd Recent Development
Table 138. Nestlé SA Company Information
Table 139. Nestlé SA Introduction and Business Overview
Table 140. Nestlé SA Semi-Solid Dosage Form Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. Nestlé SA Semi-Solid Dosage Form Product
Table 142. Nestlé SA Recent Development
Table 143. Novartis AG Company Information
Table 144. Novartis AG Introduction and Business Overview
Table 145. Novartis AG Semi-Solid Dosage Form Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 146. Novartis AG Semi-Solid Dosage Form Product
Table 147. Novartis AG Recent Development
Table 148. GlaxoSmithKline plc Company Information
Table 149. GlaxoSmithKline plc Introduction and Business Overview
Table 150. GlaxoSmithKline plc Semi-Solid Dosage Form Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 151. GlaxoSmithKline plc Semi-Solid Dosage Form Product
Table 152. GlaxoSmithKline plc Recent Development
Table 153. Bausch Health Companies Company Information
Table 154. Bausch Health Companies Introduction and Business Overview
Table 155. Bausch Health Companies Semi-Solid Dosage Form Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 156. Bausch Health Companies Semi-Solid Dosage Form Product
Table 157. Bausch Health Companies Recent Development
Table 158. Allergan plc Company Information
Table 159. Allergan plc Introduction and Business Overview
Table 160. Allergan plc Semi-Solid Dosage Form Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 161. Allergan plc Semi-Solid Dosage Form Product
Table 162. Allergan plc Recent Development
Table 163. Biofrontera, Inc. Company Information
Table 164. Biofrontera, Inc. Introduction and Business Overview
Table 165. Biofrontera, Inc. Semi-Solid Dosage Form Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 166. Biofrontera, Inc. Semi-Solid Dosage Form Product
Table 167. Biofrontera, Inc. Recent Development
Table 168. Crown Laboratories Inc. Company Information
Table 169. Crown Laboratories Inc. Introduction and Business Overview
Table 170. Crown Laboratories Inc. Semi-Solid Dosage Form Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 171. Crown Laboratories Inc. Semi-Solid Dosage Form Product
Table 172. Crown Laboratories Inc. Recent Development
Table 173. Akorn Inc. (US) Company Information
Table 174. Akorn Inc. (US) Introduction and Business Overview
Table 175. Akorn Inc. (US) Semi-Solid Dosage Form Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 176. Akorn Inc. (US) Semi-Solid Dosage Form Product
Table 177. Akorn Inc. (US) Recent Development
Table 178. Ingenus Pharmaceuticals Company Information
Table 179. Ingenus Pharmaceuticals Introduction and Business Overview
Table 180. Ingenus Pharmaceuticals Semi-Solid Dosage Form Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 181. Ingenus Pharmaceuticals Semi-Solid Dosage Form Product
Table 182. Ingenus Pharmaceuticals Recent Development
Table 183. Sun Pharmaceuticals Company Information
Table 184. Sun Pharmaceuticals Introduction and Business Overview
Table 185. Sun Pharmaceuticals Semi-Solid Dosage Form Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 186. Sun Pharmaceuticals Semi-Solid Dosage Form Product
Table 187. Sun Pharmaceuticals Recent Development
Table 188. Crescita Therapeutics Inc. Company Information
Table 189. Crescita Therapeutics Inc. Introduction and Business Overview
Table 190. Crescita Therapeutics Inc. Semi-Solid Dosage Form Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 191. Crescita Therapeutics Inc. Semi-Solid Dosage Form Product
Table 192. Crescita Therapeutics Inc. Recent Development
Table 193. Mylan N.V. Company Information
Table 194. Mylan N.V. Introduction and Business Overview
Table 195. Mylan N.V. Semi-Solid Dosage Form Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 196. Mylan N.V. Semi-Solid Dosage Form Product
Table 197. Mylan N.V. Recent Development
Table 198. Encore Dermatology, Inc. Company Information
Table 199. Encore Dermatology, Inc. Introduction and Business Overview
Table 200. Encore Dermatology, Inc. Semi-Solid Dosage Form Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 201. Encore Dermatology, Inc. Semi-Solid Dosage Form Product
Table 202. Encore Dermatology, Inc. Recent Development
Table 203. LEO Pharma Company Information
Table 204. LEO Pharma Introduction and Business Overview
Table 205. LEO Pharma Semi-Solid Dosage Form Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 206. LEO Pharma Semi-Solid Dosage Form Product
Table 207. LEO Pharma Recent Development
Table 208. Almirall, S.A Company Information
Table 209. Almirall, S.A Introduction and Business Overview
Table 210. Almirall, S.A Semi-Solid Dosage Form Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 211. Almirall, S.A Semi-Solid Dosage Form Product
Table 212. Almirall, S.A Recent Development
Table 213. Aclaris Therapeutics, Inc. Company Information
Table 214. Aclaris Therapeutics, Inc. Introduction and Business Overview
Table 215. Aclaris Therapeutics, Inc. Semi-Solid Dosage Form Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 216. Aclaris Therapeutics, Inc. Semi-Solid Dosage Form Product
Table 217. Aclaris Therapeutics, Inc. Recent Development
Table 218. Taro Pharmaceutical Industries Ltd. Company Information
Table 219. Taro Pharmaceutical Industries Ltd. Introduction and Business Overview
Table 220. Taro Pharmaceutical Industries Ltd. Semi-Solid Dosage Form Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 221. Taro Pharmaceutical Industries Ltd. Semi-Solid Dosage Form Product
Table 222. Taro Pharmaceutical Industries Ltd. Recent Development
Table 223. Teligent Pharma Company Information
Table 224. Teligent Pharma Introduction and Business Overview
Table 225. Teligent Pharma Semi-Solid Dosage Form Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 226. Teligent Pharma Semi-Solid Dosage Form Product
Table 227. Teligent Pharma Recent Development
Table 228. Perrigo Pharma Introduction and Business Overview
Table 229. Perrigo Pharma Semi-Solid Dosage Form Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 230. Perrigo Pharma Semi-Solid Dosage Form Product
Table 231. Perrigo Pharma Recent Development
Table 232. Perrigo Pharma Company Information
Table 233. Key Raw Materials Lists
Table 234. Raw Materials Key Suppliers Lists
Table 235. Semi-Solid Dosage Form Market Trends
Table 236. Semi-Solid Dosage Form Market Drivers
Table 237. Semi-Solid Dosage Form Market Challenges
Table 238. Semi-Solid Dosage Form Market Restraints
Table 239. Semi-Solid Dosage Form Distributors List
Table 240. Semi-Solid Dosage Form Downstream Customers
Table 241. Research Programs/Design for This Report
Table 242. Key Data Information from Secondary Sources
Table 243. Key Data Information from Primary Sources
List of Figures
Figure 1. Semi-Solid Dosage Form Product Picture
Figure 2. Global Semi-Solid Dosage Form Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Semi-Solid Dosage Form Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Semi-Solid Dosage Form Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Ointments
Figure 6. Global Ointments Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Gels
Figure 8. Global Gels Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Others
Figure 10. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Global Semi-Solid Dosage Form Sales by Type (2018-2029) & (US$ Million)
Figure 12. Global Semi-Solid Dosage Form Sales Market Share by Type in 2022 & 2029
Figure 13. North America Semi-Solid Dosage Form Sales Market Share in Volume by Type in 2022
Figure 14. North America Semi-Solid Dosage Form Sales Market Share in Value by Type in 2022
Figure 15. Europe Semi-Solid Dosage Form Sales Market Share in Volume by Type in 2022
Figure 16. Europe Semi-Solid Dosage Form Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Semi-Solid Dosage Form Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Semi-Solid Dosage Form Sales Market Share in Value by Type in 2022
Figure 19. Latin America Semi-Solid Dosage Form Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Semi-Solid Dosage Form Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Semi-Solid Dosage Form Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Semi-Solid Dosage Form Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Semi-Solid Dosage Form Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Semi-Solid Dosage Form Revenue in 2022
Figure 25. Semi-Solid Dosage Form Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Skin
Figure 27. Global Skin Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Nasal Cavity
Figure 29. Global Nasal Cavity Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Vaginal Cavity
Figure 31. Global Vaginal Cavity Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Rectal Cavity
Figure 33. Global Rectal Cavity Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 36. Global Semi-Solid Dosage Form Sales by Application (2018-2029) & (US$ Million)
Figure 37. Global Semi-Solid Dosage Form Sales Market Share by Application in 2022 & 2029
Figure 38. North America Semi-Solid Dosage Form Sales Market Share in Volume by Application in 2022
Figure 39. North America Semi-Solid Dosage Form Sales Market Share in Value by Application in 2022
Figure 40. Europe Semi-Solid Dosage Form Sales Market Share in Volume by Application in 2022
Figure 41. Europe Semi-Solid Dosage Form Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Semi-Solid Dosage Form Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Semi-Solid Dosage Form Sales Market Share in Value by Application in 2022
Figure 44. Latin America Semi-Solid Dosage Form Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Semi-Solid Dosage Form Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Semi-Solid Dosage Form Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Semi-Solid Dosage Form Manufacturing Cost Structure
Figure 49. Semi-Solid Dosage Form Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed